LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 110 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,195 | -37.4% | 31,372 | +31.5% | 0.00% | – |
| Q2 2023 | $54,626 | +2.8% | 23,854 | +9.1% | 0.00% | – |
| Q1 2023 | $53,151 | +30.6% | 21,873 | +2.7% | 0.00% | – |
| Q4 2022 | $40,685 | -15.2% | 21,301 | +6.7% | 0.00% | – |
| Q3 2022 | $48,000 | +60.0% | 19,957 | +23.1% | 0.00% | – |
| Q2 2022 | $30,000 | -11.8% | 16,216 | +0.7% | 0.00% | – |
| Q1 2022 | $34,000 | -44.3% | 16,100 | +3.5% | 0.00% | – |
| Q4 2021 | $61,000 | -19.7% | 15,554 | -1.1% | 0.00% | -100.0% |
| Q3 2021 | $76,000 | +5.6% | 15,732 | +0.2% | 0.00% | 0.0% |
| Q2 2021 | $72,000 | +227.3% | 15,696 | +39.8% | 0.00% | – |
| Q1 2020 | $22,000 | – | 11,227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |